نمایش پرونده ساده آیتم

dc.contributor.authorSadigh-Eteghad, S
dc.contributor.authorMajdi, A
dc.contributor.authorTalebi, M
dc.contributor.authorMahmoudi, J
dc.contributor.authorBabri, S
dc.date.accessioned2018-08-26T05:46:14Z
dc.date.available2018-08-26T05:46:14Z
dc.date.issued2015
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/41010
dc.description.abstractNicotinic acetylcholine receptors (nAChRs) seem to play an integral role in the progress and/or prevention of Alzheimer?s diseases (AD). Functional abnormalities and problems in biogenesis and trafficking of nAChRs are two major culprits in AD; on the other hand, chaperones modulate post-translational changes in nAChRs. Moreover, they indirectly regulate nAChRs by controlling AD-related proteins such as tau and amyloid beta (A?). In this review, we go through recent studies which are showing that chaperones modulate the expression of nAChRs in a subtype-specific manner and explain how AD progress is affected by nAChRs chaperoning.
dc.language.isoEnglish
dc.relation.ispartofEuropean journal of pharmacology
dc.subjectAlzheimer Disease
dc.subjectBrain
dc.subjectHumans
dc.subjectMolecular Chaperones
dc.subjectReceptors, Nicotinic
dc.titleRegulation of nicotinic acetylcholine receptors in Alzheimer?s disease: a possible role of chaperones.
dc.typearticle
dc.citation.volume755
dc.citation.spage34
dc.citation.epage41
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.1016/j.ejphar.2015.02.047


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم